The drug will be available in 5-, 7.5-, 10-, 12.5, 15-, 20- and 30-mg tablets.
The healthcare logistics industry has seen significant improvements in product security and regulatory compliance across the supply chain.
Steven Collis has served as president and CEO of AmerisourceBergen since July 2011 and a director since May 2011.
Mylan has launched its generic of Axert, a treatment for migraines.
Ajanta is launching its fifth generic product in the U.S. that has received Food and Drug administration approval.
Mylan has launched two generics — one for diabetes and another for HIV — following final Food and Drug Administration approval.
Perrigo’s shareholders did not tender a majority of the company’s shares to Mylan by 8 a.m. EST Friday, effectively ending Mylan’s acquisition attempt.
The drug is indicated to treat and prevent low levels of potassium (hypokalemia).
A merger frenzy has hit the generics sector this year with a spate of acquisitions and hostile-takeover bids making headlines and reshaping the industry.